Citigroup Maintains Buy on Insulet, Raises Price Target to $275
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Insulet (NASDAQ:PODD) and raises the price target from $250 to $275.
October 01, 2024 | 4:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch has reiterated a Buy rating for Insulet and increased the price target from $250 to $275, indicating confidence in the company's future performance.
The increase in price target from $250 to $275 by Citigroup suggests a positive outlook for Insulet's stock, likely leading to a short-term price increase. The Buy rating indicates strong confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100